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We previously reported that the chimeric DNA vaccine pcDNA-3-1E-linker-mChIL-15, fused through linking Eimeria acervulina
3-1E encoding gene and mature chicken IL-15 (mChIL-15) gene with four ﬂexible amino acid SPGS, could signiﬁcantly oﬀer
protection against homologous challenge. In the present study, the induction of cellular immune response induced by the
chimeric DNA vaccine pcDNA-3-1E-linker-mChIL-15 was investigated. Spleen lymphocyte subpopulations were characterized
by ﬂow cytometric analysis. The spleen lymphocyte proliferation assays were measured by 3-[4,5-dimethylthiazol-2-y1]-2,5-
diphenyltetrazolium bromide (MTT) method. The mRNA proﬁles of ChIL-2 and ChIFN-γ in spleen were characterized by means
of real-time PCR. Chickens immunized with pcDNA-3-1E-linker-mChIL-15 exhibited signiﬁcant upregulated level of ChIL-2 and
ChIFN-γ transcripts in spleen following two immunizations compared with chickens in other groups (P<0.01). In comparison
with pcDNA3.1-immunized and control groups, lymphocyte proliferation, percentage of CD8α+ cell, and levels of ChIL-2 and
ChIFN-γ transcripts in the group immunized with pcDNA-3-1E-linker-mChIL-15 were signiﬁcantly increased on day 6 following
challenge (P<0.05, P<0.01, and P<0.01, resp.). Our data suggested that the fusion antigen 3-1E-linker-mChIL-15 could be a
potential candidate for E. acervulina vaccine development.
1.Introduction
Coccidiosis, a major poultry enteric disease caused by pro-
tozoan parasites of the genus Eimeria, results in signiﬁcant
economic losses to the poultry industry [1]. Currently,
although chemoprophylaxis is the predominant method
used to control coccidiosis, alternate options are needed
due to the emergence of drug resistance of Eimeria species,
drug residue in animal food products, and high costs
for development of new drugs [2–7]. Live vaccines and
attenuated vaccines available commercially could provide
partial immune protection against reinfection, but also pose
the risk of unintended infection under the immunosup-
pressive conditions [8, 9]. It has been shown that host
immunity to avian coccidiosis is largely dependent on cell-
mediated immunity (CMI) [10–12], thus generating interest
in developing recombinant vaccines and adjuvants that pref-
erentially elicit cellular immune responses. Many secreted or
membrane-bound proteins involved in the interaction with
the host immune system have been considered as targets for
immunological interventions. Some antigens located on the
surface of sporozoites and schizonts have been identiﬁed as
potential immune regulator and eﬀector genes that could
inﬂuence host-parasite interaction at the molecular and
cellular levels [12–14]. The 3-1E antigen is on the surface
of Eimeria sporozoites and schizonts, and the 3-1E coding
sequence was reported to be conserved in several Eimeria
spp. [15]. The DNA vaccine carrying 3-1E gene could induce
immune protection against homologous challenge [16–19].
Some studies have reported that chicken cytokines, such
as ChIFN-α, ChIFN-γ, ChIL-1β, ChIL-2, ChIL-8, ChIL-15,
ChIL-18,andChTGF-β4,couldallenhancethehostimmune2 Journal of Parasitology Research
responses to E. tenella and E. acervulina induced by DNA
vaccines [17–25]. ChIL-15 was reported to be produced by
mononuclear phagocytes and other cell types in response
to infection by virus or parasites, LPS, and other signals.
ChIL-15 could stimulate the proliferation of NK cells [26].
Activated NK cells could produce ChIFN-γ,w h i c hi sam a j o r
cytokine mediating resistance to Eimeria.P r e v i o u s l y ,w e
constructed a chimeric DNA vaccine, pcDNA-3-1E-linker-
mChIL-15, coexpressing E. acervulina 3-1E encoding gene
and mature ChIL-15 (mChIL-15) gene, and the evalua-
tion of its protective eﬃcacy showed that pcDNA-3-1E-
linker-mChIL-15 could signiﬁcantly oﬀer protection against
homologouschallenge[27].Theaimofthepresentstudywas
to investigate the cellular immune response induced by the
chimeric DNA vaccine pcDNA-3-1E-linker-mChIL-15.
2.MaterialsandMethods
2.1. Birds, Parasites, and DNA Vaccine. Speciﬁc pathogen-
free (SPF) White Leghorn chickens were purchased from
Harbin Veterinary Research Institute (Harbin, China) and
raised in wire cages in the Eimeria-free environment.
Oocysts of E. acervulina Shanghai (SH) strain were pro-
vided by Dr. Huangbing (Shanghai Veterinary Research
Institute, Shanghai, China). The sporulated oocysts were
propagated in three-week-old SPF chickens and were stored
in 2.5% potassium dichromate solution at 4◦C[ 28]. The
DNA vaccine pcDNA-3-1E-linker-mChIL-15 was prepared
asdescribedpreviously[27]andwasstoredintheLaboratory
of Veterinary Immunopathology, Northeast Agricultural
University, China.
2.2. Immunization and Challenge Experiment. The immu-
nization and challenge experiments were carried on accord-
ing to the previous report [27]. Brieﬂy, seven-day-old
chickens were randomly divided into three groups of 25
each. The chickens in the experimental group were, respec-
tively, intramuscularly immunized with 100μg pcDNA-3-
1E-linker-mChIL-15(group1)and100μgpcDNA3.1(group
2) at 14 days of age. Chickens in the control group (group
3) were injected with sterile TE buﬀer (10mM Tris-HCl pH
7.6 and 1mM EDTA) at the same injection site. A booster
immunization was given at 21 days of age. At 28 days of age,
all chickens were inoculated orally with 5 × 104 sporulated
oocysts of E. acervulina SH strain (Table 1). The challenge
dose of E. acervulina-sporulated oocysts was determined
accordingtotheresultsofpreliminaryexperimentinourlab.
2.3. Lymphocyte Proliferation Assay. Spleen samples from
ﬁve chickens per group were randomly collected at 28 and
34 days of age, respectively. The samples were divided into
two equal parts. One is for preparation of lymphocytes,
the other is used to extract RNA for real-time PCR assay.
The splenocytes were isolated on lymphocyte separation
medium with a speciﬁc density of 1.007g/mL (Tianjin
Haoyang, Tianjin, China) according to the procedure as
reported [29]. Brieﬂy, the lymphocytes were collected and
washed twice with culture medium (RPMI1640 containing
10% FCS, pH 7.2). Then it was ﬁnally resuspended in the
culture medium at a concentration of 2 × 107 cells/mL.
50μL of lymphocyte suspension was transferred into a 96-
well tissue microculture plate (Costar, USA) on ice, and
then 50μL concanavalin A (Con A) solution (0.02mg/mL,
Sigma) was added per well. After 24h of culture at 39◦C
under 5% CO2,1 0 μL of 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) (5mg/mL, Sigma)
solution was added to each well and continued to incubate
for 4h. The microtiter plates were centrifuged for 5min
(1400g, 15◦C), and then 150μL of a dimethyl sulfoxide
(DMSO) working solution was added to each well. The
optical density (OD) of the reaction product was measured
in an ELISA reader at 570nm wavelength 15 minutes later.
2.4. Flow Cytometric Analysis. For evaluation of cellular
immunity, single cell suspensions of spleen lymphocytes
were prepared as described previously, resuspended in
culture medium (RPMI1640 containing 10% FCS, pH 7.2),
and adjusted to concentration of 1.0 × 107 cells/mL. The
cells were respectively incubated with 5μL of ﬂuorescein-
isothiocyanate-(FITC-)conjugatedmousemonoclonalanti-
bodies(mAbs)againstchickenCD4+ (AbDSerotec)and5μL
of FITC-conjugated mouse mAbs against chicken CD8α+
(AbD Serotec) for 30min at room temperature. Following
incubation, the cells were washed twice with PBS (pH 7.2),
and the proportion of CD4+ and CD8α+ cells was analyzed
with 1.0 × 104 viable cells using EPICS XL ﬂow cytometer
(Beckman Coulter).
2.5. RNA Extraction and cDNA Preparation. The spleen
samples about 100mg were homogenized with liquid nitro-
gen using a mortar and pestle. Total RNA was extracted
from the tissue samples with 1.0mL TRIzol reagent (Invit-
rogen) according to the manufacturer protocol. Prior to
reverse transcription RNA was treated with RNase-free
DNase (Invitrogen). Quantiﬁcation of RNA was based on
spectrophotometric analysis at 260/280nm. Then, total RNA
was reverse-transcribed using SYBR Premix Ex Taq kit
(DRR037S, TaKaRa, Japan) according to the manufacture
manual. The cDNA product was stored at −20◦C.
2.6. Real-Time PCR Assay. For quantiﬁcation, three kinds
of standard plasmids with the cDNA fragment of ChIL-
2, ChIFN-γ and GAPDH harbored in pMD18-T (TaKaRa,
Japan) were, respectively, constructed. The standard curves
of the three standard plasmids were prepared in order to
relatively quantify the threshold cycles (Ct)v a l u e so ft h e
samples. Real-time PCR was done as described by Hong
et al. [14]. Triplicate quantitative assays per group were
performed with an ABI prism 7000 sequence detection
system. Primers and PCR conditions are described in
Table 2. The negative control containing reagents only and
the tenfold serial dilutions of standard plasmid with target
gene fragment were included in all assays. The standard
curve was generated using log10 diluted standard plasmid
by ABI prism 7000 Sequence Detection System (SDS) v1.2.3
software. The mRNA expression level of ChIL-2, ChIFN-γ,Journal of Parasitology Research 3
Table 1: Experimental groups used in immunization and challenge experiments.
Group Number
Immunization C h a l l e n g ea t2 8d a y so fa g e
Primary immunization at 14 days
of age
Secondary immunization at 21
days of age
Number of E. acervulina-sporulated
oocysts
1 25 pcDNA-3-1E-mChIL-15 (100μg) pcDNA3-1E-mChIL-15 (100μg) 5 × 104
2 25 pcDNA3.1 (100μg) pcDNA3.1 (100μg) 5 × 104
32 5 T E b u ﬀer (pH 7.6) TE buﬀer (pH 7.6) 5 × 104
Table 2: Primer sequences and PCR conditions. The oligonucleotides were used to analyze the relative expression level of ChIL-2 and
ChIFN-γ mRNA.
mRNA target GeneBank
accession no. Primer sequence PCR product Size
(bp)
Annealing temperature.
(◦C)
ChIL-2
NM204153
F5  -GTGGCTAACTAATCTGCTGTCC-3 
105 55.5 R5  -GTAGGGCTTACAGAAAGGATCAA-3 
ChIFN-γ
NM205149
F5  -CAAAGCCGCACATCAAACAC-3 
80 56.0 R5  -tTTCACCTTCTTCACGCCATC-3 
ChGAPDH
NM204305
F5  -AGAACATCATCCCAGCGTCC-3 
133 57.5 R5  -CGGCAGGTCAGGTCAACA-3 
and GAPDH in spleen of individual chickens was calculated
using speciﬁc standard curve and was then divided by that
of GAPDH of the same chicken to normalize the relative
expression of ChIL-2 and ChIFN-γ mRNA.
2.7. Statistical Analyses. Data were all expressed as means ±
SD and were all evaluated by variance (ANOVA). Duncan’s
multiplerangetestswereperformedusingStatisticalAnalysis
System (SAS Institute, Cary, NC, USA) to analyze diﬀerence
between means. Results were considered signiﬁcant at P<
0.05 highly signiﬁcant at P<0.01.
3. Results
3.1. Eﬀect of Immunization with pcDNA-3-1E-Linker-mChIL-
15 on Spleen Lymphocyte Proliferation. The spleen lym-
phocyte proliferation response to stimulation with Con A
measured by MTT method is described in Figure 1.T h e
proliferationresponseinthegroupimmunizedwithpcDNA-
3-1E-linker-mChIL-15 (group 1) was higher than that in the
other two groups at 34 days of age (on day 6 after challenge)
(P<0.05).
3.2. Eﬀect of Immunization with pcDNA-3-1E-Linker-mChIL-
15 on Spleen Lymphocyte Subpopulations. Chicken lympho-
cytes have an important role in the host immune response
to Eimeria infection. Therefore, we measured the changes
of spleen lymphocyte subpopulations in chickens on day 7
after secondary immunization (28 days of age) and on day
6 after challenge (34 days of age). Chickens in the group
immunized with pcDNA-3-1E-linker-mChIL-15 exhibited
signiﬁcant increased percentage of CD8α+ cells compared
with the other two groups on day 6 after challenge (P<0.01)
(Figure 2).
3.3. Eﬀect of Immunization with pcDNA-3-1E-Linker-mChIL-
15 on Splenic Cytokine mRNA Level. The level of mRNA for
ChIL-2 and ChIFN-γ in spleen of chickens in each group was
illustrated in Figure 3. Following two immunizations (at 28
days of age), chickens immunized with pcDNA-3-1E-linker-
mChIL-15 (group 1) showed signiﬁcant increased level of
transcriptsforChIL-2andChIFN-γ comparedwithchickens
in pcDNA3.1-immunized and nonimmunized groups (P<
0.01). On day 6 after challenge (at 34 days of age), the level of
transcripts for cytokines in group 1 was signiﬁcantly higher
(P<0.01) for ChIL-2 and higher (P<0.05) for ChIFN-γ
compared with that in group 2 and group 3.
4. Discussion
It has been well documented that DNA immunization
could elicit protective immunity against pathogenic para-
sites, including Eimeria sp., Leishmania sp., and Toxoplasma
gondii [27, 30–32]. Several important antigens existing in
sporozoites and schizonts including 3-1E and EtMIC2 [17,
33], SO7 [30], TA4 [34], 5401 [35], EASZ240 and EASZ250
[36], and rhomboid-like protein [37]h a v ea l r e a d yb e e n
evaluated to be immunogenic. 3-1E antigen was presented
on the outer surface of both sporozoites and merozoites. The
3-1E gene as DNA vaccine candidate and a series of chicken
cytokine as adjuvant of DNA vaccine have been reported [18,
19, 24]. We also successfully constructed a novel chimeric
DNA vaccine, pcDNA-3-1E-linker-mChIL-15, coexpressing
E. acervulina 3-1E gene and mature ChIL-15 (mChIL-15)
in our previous studies for the ﬁrst time, and the animal
experiments showed that the chimeric DNA vaccine could
oﬀer protection against homologous challenge, including
signiﬁcantly increasing oocyst decrease ratio, reducing the
average lesion score in the duodenum, improving body4 Journal of Parasitology Research
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Figure 1: Eﬀect of immunization with pcDNA-3-1E-mChIL-
15 on spleen lymphocyte proliferation. Seven-day-old chickens
were divided into three groups. Chickens in each group were,
respectively, intramuscularly immunized with 100μgp c D N A - 3 -
1E-linker-mChIL-15 (group 1), 100μgp c D N A 3 . 1( g r o u p2 ) ,a n d
sterile TE buﬀer (pH 7.6) (group 3) at 14 days of age. A booster
immunization was given at 21 days of age. All chickens were
inoculated orally with 5 × 104 sporulated oocysts of E. acervulina
at 28 days of age (day 7 after secondary immunization). The
proliferative response of spleen lymphocytes to stimulation with
Con A was measured by MTT methods at day 28 and 34 days of age
(day 6 after challenge). Data were expressed as means ± standard
errors (n = 5 per group). Bars not sharing the same small letter
are signiﬁcantly diﬀerent according to Duncan’s multiple range test
(P<0.05) in each time point.
weight gain, and increasing anticoccidial index (ACI) [27].
However, the cellular immune response elicited by chimeric
DNA vaccine coexpressing 3-1E gene and mChIL-15 has not
been reported until now. So the purpose of the present study
was to elucidate the cellular immune response induced by
pcDNA-3-1E-linker-mChIL-15.
On day 7 following two immunizations, the signiﬁcant
increased level of mRNA for ChIL-2 and ChIFN-γ in spleen
was observed in group 1 compared with group 2 and 3
(P<0.01). The above results may be explained by the
following aspects. In our previous report, the expression of
3-1E-linker-mChIL-15fusionproteinswaseasilyobservedin
vitro in the cytoplasm of transfected 293T cells by indirect
ﬂuorescent antibody test [27]. This suggested that the
antigen 3-1E-linker-mChIL-15 could be naturally processed
and targeted to the major histocompatibility complex class I
(MHC I) binding pathway [38].
Analysis of lymphocyte subpopulation in spleen includ-
ing CD4+ and CD8α+ provides important support for
measuring the induction of cellular immune response after
immunization with pcDNA-3-1E-linker-mChIL-15. On day
6 after challenge, the chickens immunized with pcDNA-3-
1E-linker-mChIL-15 displayed signiﬁcant increased spleen
lymphocyte proliferation and percentage of CD8α+ cell (P<
0.05, P<0.01, resp.). It is generally accepted that the cell-
mediated immunity (CMI) in particular mediated by CD8α+
cytotoxic T lymphocytes plays a critical role in mediating
protective immunity during avian coccidiosis [39]. The
percentage of CD8α+ cells in spleen may partially reﬂect the
enhanced cellular immune status against Eimeria infection.
T h eh o s tc e l li m m u n er e s p o n s et oEimeria infection
could be initiated, immunoregulated, and ampliﬁed through
cytokines net [14]. On day 6 after challenge, the signiﬁcantly
increased ChIL-2 and ChIFN-γ transcripts (P<0.01, and
P<0.05, resp.) in group 1 were observed. ChIFN-γ is an
important cytokine mediating protective immune response
to avian coccidiosis and has been shown to inhibit E. tenella
development in vitro [23, 40]. ChIL-2 could selectively
enhance the diﬀerentiation and development of Th1 type
cells that could conversely induce the secretion of ChIFN-γ
and ChIL-2. It has been reported that a signiﬁcant increase
of ChIL-2 mRNA transcripts was observed in the spleen
and intestine after primary and secondary infections with E.
acervulina [41]. On day 6 after challenge, the E. acervulina
has completed its intracellular life cycle and is excreted.
Therefore, the above results in this study suggested that
the cellular immune response against E. acervulina infection
was eﬀectively induced and the invasion of sporozoites
or merozoites into the gut epithelial cells was blocked by
immunization of DNA vaccine pcDNA-3-1E-linker-mChIL-
15. All the above results and analysis are in accordance
with the previous observation of protection eﬃcacy against
homologous challenge, such as increasing oocyst decrease
ratio and reducing the average lesion score in the duodenum
[27]. The fusion protein 3-1E-linker-mChIL-15 was fused
through linking 3-1E protein and mChIL-15 protein with
four ﬂexible amino acid SPGS, which could make the two
polypeptide fragments and side chains of amino acids fold
correctly to produce a spatial structure with biological activ-
ity and function. To further explore the detailed mechanism
ofcellularimmune response inducedbyfusionprotein 3-1E-
linker-mChIL-15, we prepare to design more experimental
groups in our subsequent research, containing pcDNA3-1E
group, pcDNAChIL-15 group, and pcDNA3-1E coinjected
with pcDNAChIL-15 group.
Recently, several studies have investigated the important
role of TNF superfamily (such as TNFSF-15) and IL-
17 family (such as IL-17F) in the regulation of immune
response during infection of Eimeria [42–44]. In addition,
it was reported that the antibody-mediated immunity also
played roles against the Eimeria infection [45, 46]. So,
one of the current works in our laboratory is directed at
investigating the more detailed immune mechanisms of the
novel chimeric DNA vaccine pcDNA-3-1E-linker-mChIL-15
including humoral immunity and innate immunity such as
the Toll-like receptor (TLR) signal pathway.
In conclusion, our data indicated that the cellular
immune response for administration of 3-1E-linker-mChIL-
15 involved signiﬁcant increased lymphocytes proliferation,
percentage of CD8α+ cells, and mRNA level of ChIL-2 and
ChIFN-γ in spleen on day 6 after challenge.
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Figure 2:FlowcytometricanalysisofCD4 + andCD8α+ cellsisolatedfromsplenocytesofchickens.Chickensineachgroupwere,respectively,
intramuscularly immunized with 100μg pcDNA-3-1E-linker-mChIL-15 (group 1), 100μg pcDNA3.1 (group 2), and sterile TE buﬀer (pH
7.6) (group 3) at 14 and 21 days of age. All chickens were inoculated orally with 5 × 104 sporulated oocysts of E. acervulina at 28 days of age
(day 7 after secondary immunization). The ratio of CD4+ and CD8α+ cells in spleen of randomly selected ﬁve chickens was assayed at 28
and 34 days of age (day 6 after challenge). Data represent mean ± standard errors (n = 5 per group). Highly signiﬁcant diﬀerence (P<0.01)
between bars not sharing the same capital letters in each time point. Signiﬁcant diﬀerence (P<0.05) between bars not sharing the same
small letters in each time point.
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Figure 3:Eﬀect ofimmunization withpcDNA-3-1E-mChIL-15onChIFN-γ andChIL-2mRNAlevels.Seven-day-old chickensweredivided
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